| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 32.52▼ | 33.04▼ | 33.19▼ | 33.66▼ | 37.66▼ |
| MA10 | 32.70▼ | 33.24▼ | 33.47▼ | 35.36▼ | 36.00▼ |
| MA20 | 33.13▼ | 33.65▼ | 34.00▼ | 37.70▼ | 34.21▼ |
| MA50 | 33.89▼ | 34.94▼ | 36.00▼ | 35.60▼ | 30.07▲ |
| MA100 | 34.82▼ | 37.33▼ | 38.11▼ | 34.09▼ | 25.64▲ |
| MA200 | 36.91▼ | 37.89▼ | 36.85▼ | 30.75▲ | 23.78▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.043▼ | -0.044▼ | -0.015▼ | -0.863▼ | -0.129▼ |
| RSI | 35.080▼ | 31.075▼ | 29.560▼ | 34.707▼ | 48.055▼ |
| STOCH | 16.399▼ | 23.622 | 18.741▼ | 6.348▼ | 68.089 |
| WILL %R | -89.815▼ | -91.791▼ | -91.791▼ | -98.357▼ | -74.641 |
| CCI | -62.365 | -147.372▼ | -181.324▼ | -111.617▼ | -57.963 |
|
Thursday, January 29, 2026 01:28 AM
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its recent ...
|
|
Wednesday, January 28, 2026 04:13 PM
Ryoncil ® gross sales for the quarter were US$35 million, a 60% increase on the prior quarter ended September 30, 2025, and net revenues were US$30 million. 1 ...
|
|
Monday, January 26, 2026 04:02 PM
To ensure that no patient is left behind in receiving this potentially life-saving therapy, Mesoblast has established a patient access hub termed MyMesoblast™, where Ryoncil ® is available for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/01/26 | 32.34 | 32.855 | 32.34 | 32.505 | 25,095 |
| 29/01/26 | 33.91 | 34.90 | 33.245 | 33.63 | 32,267 |
| 28/01/26 | 34.04 | 34.975 | 33.0001 | 33.91 | 35,272 |
| 27/01/26 | 33.97 | 34.99 | 33.38 | 34.14 | 37,804 |
| 26/01/26 | 35.60 | 35.94 | 33.815 | 34.10 | 82,165 |
| 23/01/26 | 36.35 | 37.12 | 35.11 | 35.50 | 29,420 |
| 22/01/26 | 37.33 | 37.505 | 36.1801 | 36.52 | 20,580 |
| 21/01/26 | 36.05 | 37.3301 | 35.00 | 36.68 | 92,272 |
| 20/01/26 | 39.20 | 39.21 | 35.00 | 35.69 | 140,880 |
| 16/01/26 | 40.44 | 41.96 | 40.25 | 40.96 | 22,864 |
|
|
||||
|
|
||||
|
|